VL
Insider
VHCP Management III, LLC
10% ownerVHCP Management III, LLC (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (2 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in KALV. Across 1 priced purchase filing, the average 21-session return was +6.9% from execution and +13.9% from disclosure (delay-adjusted; derived). The largest single filing was $1.4M of ORKA (122,308 sh across 4 lots, as filed), executed Feb 11 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+6.9%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+13.9%
same 1 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells · 1 late
Median delay
10d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Feb 14 2025
Filed Feb 27 2025
Median ADV $139.8M across their filed names
50% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $2.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
KALV
KALV
KALV · 1 buy · 0 sells
1 filing
ORKARecent filings
ORKAPURCHASE
Oruka Therapeutics, Inc.
View filing →
$1.4M122,308 sh across 4 lots
Exec Feb 11 2025
Filed Feb 27 2025 · 5:30 PM ET † KALVPURCHASE KalVista Pharmaceuticals, Inc. View filing → $622K
70,023 sh across 3 lots
Exec Jan 30 2025
Filed Feb 3 2025 · 5:30 PM ET